Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Eligible patient population and bevacizumab treatment schedules in 4 peer-reviewed RCTs.

More »

Table 1 Expand

Table 2.

OS hazard ratios.

More »

Table 2 Expand

Table 3.

QoL values.

More »

Table 3 Expand

Table 4.

Mean treatment duration and bevacizumab treatment costs.

More »

Table 4 Expand

Table 5.

IC, IE & ICERs for the base case scenario (GOG-0218 (st.IV), ICON7 (high risk), OCEANS, and AURELIA).

More »

Table 5 Expand

Fig 1.

Results of the economic evaluation for the GOG-0218 trial.

More »

Fig 1 Expand